Treatment With SU11248 in Patients With Neuroendocrine Tumors

NCT00056693 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer